NATH BIOGENES (INDIA)
Quarterly Results Analysis [Dec2023]
NATH BIOGENES (INDIA) Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹32 Cr | ₹23 Cr | ₹235 Cr | ₹45 Cr | ₹25 Cr | ₹22 Cr | ₹209 Cr | ₹27 Cr |
Expenses | ₹26 Cr | ₹17 Cr | ₹198 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr | ₹175 Cr | ₹49 Cr |
Operating Income | ₹6 Cr | ₹6 Cr | ₹37 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹34 Cr | ₹-21 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹5 Cr | ₹2 Cr | ₹33 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹31 Cr | ₹-113 Cr |
Profit After Tax | ₹4 Cr | ₹2 Cr | ₹33 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹31 Cr | ₹-116 Cr |
EPS | ₹2.01 | ₹1.07 | ₹17.47 | ₹0.76 | ₹0.71 | ₹0.77 | ₹16.18 | ₹-61.22 |
Industry Peers & Returns | 1W | 1M | 1Y |
NATH BIOGENES (INDIA) | 0.8% | -15.2% | 27.9% |
BOMBAY BURMAH TRADING CORPORATION | 1.9% | -9.3% | 86.3% |
KAVERI SEED COMPANY | -1.5% | -5.4% | 22.2% |
VENKYS (INDIA) | -0.4% | -13.5% | -1.3% |
BOMBAY SUPER HYBRID SEEDS | NA | -11.6% | -31.3% |
TIERRA AGROTECH | 3.7% | -21.5% | -47.8% |
INDO US BIOTECH | -12.2% | -26.8% | 173% |
MANGALAM SEEDS | NA | NA | NA |
SHREE OSWAL SEEDS AND CHEMICALS | -9.4% | -19.3% | -35.2% |
NATH BIOGENES (INDIA) Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 40.63 % |
Y-o-Y | 25.46 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹32 Cr | 40.63 | |
Sep2023 | ₹23 Cr | -90.41 | |
Jun2023 | ₹235 Cr | 422.99 | |
Mar2023 | ₹45 Cr | 77.84 | |
Dec2022 | ₹25 Cr | 16.42 | |
Sep2022 | ₹22 Cr | -89.62 | |
Jun2022 | ₹209 Cr | 669.33 | |
Mar2022 | ₹27 Cr | - |
NATH BIOGENES (INDIA) Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 2.38 % |
Y-o-Y | 0.55 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹6 Cr | 2.38 | |
Sep2023 | ₹6 Cr | -85.02 | |
Jun2023 | ₹37 Cr | 835.40 | |
Mar2023 | ₹4 Cr | -29.92 | |
Dec2022 | ₹6 Cr | 18.11 | |
Sep2022 | ₹5 Cr | -86.20 | |
Jun2022 | ₹34 Cr | Positive | |
Mar2022 | ₹-21 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -27.21 % |
Y-o-Y | -19.86 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 17.79% | -27.21 | |
Sep2023 | 24.44% | 56.27 | |
Jun2023 | 15.64% | 78.74 | |
Mar2023 | 8.75% | -60.59 | |
Dec2022 | 22.2% | 1.46 | |
Sep2022 | 21.88% | 33.01 | |
Jun2022 | 16.45% | Positive | |
Mar2022 | -78.28% | - |
NATH BIOGENES (INDIA) Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 87.57 % |
Y-o-Y | 183.10 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹4 Cr | 87.57 | |
Sep2023 | ₹2 Cr | -93.86 | |
Jun2023 | ₹33 Cr | 2,207.44 | |
Mar2023 | ₹1 Cr | 6.60 | |
Dec2022 | ₹1 Cr | -8.11 | |
Sep2022 | ₹1 Cr | -95.23 | |
Jun2022 | ₹31 Cr | Positive | |
Mar2022 | ₹-116 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 33.37 % |
Y-o-Y | 125.70 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 12.03 % | 33.37 | |
Sep2023 | 9.02 % | -36.03 | |
Jun2023 | 14.1 % | 340.63 | |
Mar2023 | 3.2 % | -39.96 | |
Dec2022 | 5.33 % | -21.15 | |
Sep2022 | 6.76 % | -53.98 | |
Jun2022 | 14.69 % | Positive | |
Mar2022 | -427.51 % | - |
NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 87.85 % |
Y-o-Y | 183.10 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹2.01 | 87.85 | |
Sep2023 | ₹1.07 | -93.88 | |
Jun2023 | ₹17.47 | 2,198.68 | |
Mar2023 | ₹0.76 | 7.04 | |
Dec2022 | ₹0.71 | -7.79 | |
Sep2022 | ₹0.77 | -95.24 | |
Jun2022 | ₹16.18 | Positive | |
Mar2022 | ₹-61.22 | - |
You may also like the below Video Courses
BOMBAY BURMAH TRADING CORPORATION LTD vs KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD
BOMBAY SUPER HYBRID SEEDS LTD vs TIERRA AGROTECH LTD vs INDO US BIOTECH LTD